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ABSTRACT 
 
We describe a new approach for reliably isolating one-step real-time quantitative RT-PCR-quality RNA from laser 
captured cells retrieved from frozen sections previously subjected to immunofluorescent immunohistochemistry (IF-
IHC) and subsequently subjected to fluorogenic one-step real-time RT-PCR analysis without the need for costly, time-
consuming linear amplification. One cell’s worth of RNA can now be interrogated with confidence. This approach 
represents an amalgam of technologies already offered commercially by Applied Biosystems, Arcturus and Invitrogen. 
It is the primary focus of this communication to expose the details and execution of an important new LCM RNA 
isolation technique, but also provide a detailed account of the IF-IHC procedure preceding RNA isolation, and provide 
information regarding our approach to fluorogenic one-step real-time RT-PCR in general. Experimental results shown 
here are meant to supplement the primary aim and are not intended to represent a complete scientific study. It is 
important to mention, that since LCM-RT-PCR is still far less expensive than micro-array analysis, we feel this 
approach to isolating RNA from LCM samples will be of continuing use to many researchers with limited budgets in 
the years ahead. 
 
 
INTRODUCTION 
 
About 9 years ago (in 1997), Lance Liotta, M.D., Ph.D., chief of 
the Laboratory of Pathology at the National Cancer Institute, 
and his laboratory published an article in Science that described 
the process of laser capture microdissection (LCM). This 
invention was driven by the need to isolate pure pre-
malignant cells from the native surrounding tissue to 
facilitate the study of molecular events leading to 
invasive cancer, and has helped to advance science in 
many ways. LCM has enabled researchers to analyze 
purified populations of cells directly from patient tissue  
 
 
samples and to achieve accurate molecular analyses in 
such samples. By using a low-power infrared laser to 
capture individual cells or pure cell populations, LCM 
ensures that RNA and DNA remain undamaged during 
the microdissection process. To study the genetic 
changes that occur in transition from a normal to an 
invasive cell, cell subpopulations, sometimes 
representing <5% of the total tissue, need to be isolated to 
reduce contamination from other cell types. Before LCM, 
the process of isolating specific cell populations from 
tissue was extremely difficult. To perform LCM, a slide 
containing tissue of interest is placed under a microscope 
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and the image is brought up on a computer screen. Cells 
of interest are selected with a joystick and at the push of a 
button an infrared laser melts a special film above the 
targeted cells. The film then sets, and the user pulls the 
chosen cells away from the tissue slide. These selected 
cells are ready for molecular analysis (i.e. RNA isolation 
and one-step fluorogenic real-time RT-PCR). The 
remaining tissue on the slide is still intact and can be 
subjected to further dissection (if the tissue is still 
sufficiently dehydrated). It has been observed that 
microdissected cells display very different genetic 
profiles when compared to cultured cells. Many new 
genes have been identified in microdissected cells. In 
contrast to cells in culture, cells obtained by LCM are in 
their natural environment and express their ‘true’ set of 
genes, and are therefore thought to be better suited for 
molecular analysis (1). LCM technology is applied using 
the AutoPix and PixCell II LCM instruments available 
exclusively from Arcturus (please see the following link 
to Arcturus for more details on the history, application 
and other LCM-related information: 
http://www.arctur.com/lab_portal/support/faq/). Extraction of 
RNA from LCM samples for use in one-step real-time 
RT-PCR has been approached several ways over the past 
few years, and this publication describes for the first 
time, the shortest, most fail-safe method for LCM sample 
RNA extraction which combines the use of technologies 
developed by three major companies; Invitrogen, 
Applied Biosystems Inc., and Arcturus. Our direct work 
with Invitrogen on this procedure, we feel, represents a 
major breakthrough since we have identified the crucial 
points during LCM RNA isolation which most affect the 
usability of the resulting LCM sample isolates in the one-
step real-time RT-PCR application. We can now 
consistently detect our one-step real-time qRT-PCR 
targets of interest within single cell amounts of total 
LCM cell [RNA] isolate. 
 
EXPERIMENTAL PROCEDURES 
 
Immunofluorescence immunohistochemistry 
 
Freshly-necropsied lung tissues from sheep are placed 
into plastic disposable base molds (disposable base 
molds, Cat. No. 03040, Surgipath Medical Industries 
Richmond, IL) containing OCT (Cat. No. 25608-930, 
Tissue-Tek OCT, VWR International, Batavia, IL), more 
OCT is applied over the tissues, and these are then 
placed onto blocks of dry ice until the tissues and OCT 
are frozen to a solid white. All samples are then 
transferred immediately to -80°C for storage. LCM 
tissues are cut with a cryostat (Leica CM 1900) into 6 µm 
LCM sections, and sections are placed onto precleaned 
superfrost plus 25 x 75 x 1mm glass slides (Cat. No. 
48311-703, VWR Scientific, West Chester, PA) at -25°C 
(see Fig. 15). This procedure is considered a standard 
Leica microtome procedure (see: 
http://www.hbu.de/range.htm). In accordance with 
Arcturus (Arcturus, Mountain View, CA) protocol 
suggestions, we did not dry the sections after cutting, we 
instead stored them (directly after cutting onto slides) 
first at -20°C in a box inside the cryostat itself, then at -
80°C for durations of anywhere from 0 to 8 days (with no 
additional OCT applied) without noticeable loss of 
immunofluorescence or real-time signals from all such 
sections. After 8 days, real-time signals started showing a 
severe decline. Upon retrieval from -80°C for use in IF-
IHC-LCM, slides are either treated as in Figure 16 (in 
cases where no IF-IHC procedure is to precede LCM) or, 
they are quickly transferred into cold nuclease-free PBS 
(made with HPLC-grade water, Fisher Scientific, 
Hanover, IL, PBS tablets and 0.1% Tween 20, Sigma, St. 
Louis, MO) within 30 seconds of their removal from the 
freezer (apparently, RNA degradation sets in very 
rapidly if this particular maneuver is not performed 
quickly; according to an Arcturus field technician). The 
PBS is inside 5-slide plastic mailers (Cat. No. 240-3074-
030, Evergreen Scientific, Los Angeles, CA). After 1 
minute in cold PBS, slides are moved into a fresh cold (4-
8°C) PBS bath for 5 minutes. Carefully, a small region 
above and below each tissue is dried off with a clean 
absorbent Terri cloth, and a PAP-pen (liquid wax pen 
from BioGenex, San Ramon, CA) is used to draw a line 
above and below each tissue section on each slide (care is 
taken to avoid flooding liquid wax over the sections by 
pressing down too hard on the PAP-pen during use; 
these pens are not certified to be nuclease-free so be extra 
careful where their contents end up). Next, an IF-IHC 
procedure is carried out as follows: after all IF-IHC 
reagents are pre-cooled to 4°C, blocking solution 
(comprised of 1% normal goat serum “NGS,” Sigma, and 
1% normal swine serum “NSS,” Invitrogen, Grand 
Island, NY, added to Common Antibody Diluent, 
BioGenex) is added to the sections for 5 minutes. Then, in 
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a cold room at 4°C (Figs. 1 and 2), sections are incubated 
for 10 minutes with a primary:biotinylated-secondary-
antibody complex (prepared by mixing equal volumes of 
primary mouse monoclonal anti-human CD208 IgG (Cat. 
No. IM3448, anti-human CD208 (DC-LAMP) purified 0.2 
mg/ml, Beckman Coulter, Miami, FL) or mouse 
monoclonal anti-bRSV-4 IgG (Dr. Kenneth Platt, 
CVM/ISU, Ames, IA) and a 1 mg/ml solution of 
biotinylated goat anti-mouse secondary IgG (in 50% 
glycerol) (Kirkegaard & Perry, Gaithersburg, MD)), with 
an additional amount of BioGenex Common Antibody 
Diluent (comprising 28% of the final primary-
biotinylated secondary mixture volume) (see Figs. 1 and 
2 for set-up depictions). 
 
 
Fig. 1: 2 slides being stained by IF-IHC (preceding LCM) are shown in the 
middle of a metal slide rack within a larger, humidified and sealable 
container. 
 
This mixture is vortexed gently then incubated for 45 
minutes to 1 hour at 37°C (this is routinely performed a 
day prior to the IF-IHC-LCM procedure). Slides are 
subsequently washed three times with cold nuclease-free 
PBS + 0.1% Tween 20 within 2 minutes, then Cy3-
streptavidin reagent (Rockland, Inc., Gilbertsville, PA), 
diluted 1:300 (with BioGenex Common Antibody Diluent 
containing 1% NGS and 1 %NSS) is added to the sections 
for 10 minutes, followed again by three washes with cold 
nuclease-free PBS + 0.1% Tween 20, within 2 minutes. For 
dehydration prior to LCM, sections are put through a 
series of solvents also contained in nuclease-free 5-slide 
plastic mailers. First, sections are placed into nuclease-
free 75% ethanol for 30 seconds, 95% nuclease-free 
ethanol for 30 seconds, twice into extra-dry or very fresh 
100% ethanol for 30 seconds, ultra fresh xylene for 5 
minutes, then again into ultra fresh xylene for 10 minutes 
up to 2 hours (this parameter is left adjustable depending 
on how many slides one is handling). 
 
 
Fig. 2: For immunofluorescence immunohistochemistry (IF-IHC) 
procedure: Humidified chamber (containing the slides on the metal slide 
rack) being placed inside a cold room at 4°C. Notice the small leveling 
device atop the container to ensure that reagent run-off is not allowed. 
 
Laser capture microdissection (LCM) 
 
Just before LCM, slides are dried for 15 minutes under a 
laminar flow hood and immediately placed inside a 
desiccator (with fresh desiccant) until subjected to LCM. 
LCM is routinely performed on each section within 40 ± 
20 minutes of their removal from ultra fresh xylene. 
 
 
Fig. 3: The Arcturus PixCell II LCM System. 
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The LCM laser power settings (on the PixCell II LCM 
system, Arcturus, Figs. 3-5) we use for cell capture 
typically start at 80 milliwatts (mW) for a duration of 800 
µsec (giving us a calculated spot size of 10 µm); but these 
settings are frequently adjusted in order to address each 
slide individually to optimize cell pick-up (up to 100 mW 
for 1 msec). 
 
 
Fig. 4: Another view of the PixCell II LCM system. 
 
Most single laser shots exacted on our ovine lung 
sections result in the capture of 1 to 3 cells at a time, even 
when the laser spot is adjusted to its smallest possible 
diameter, so great care is taken to make sure only 
specifically-intended cells and/or groups of cells are 
accurately retrieved. 
 
 
Fig. 5: Using fluorescence for IF-IHC-stained sections during LCM. 
For lung tissue, we typically use an objective lens setting 
of 20X to inspect our IF-IHC stained sections during laser 
capture; the field images are clear and identifying 
different cell types is relatively easy (Figs. 6-8). After all 
cells of interest are harvested onto HS LCM caps (Cat. 
No. LCM 0214, Arcturus), total RNA is isolated from 
captured cells using our own method (Figs. 17-22) which 
represents a combination of Arcturus, Invitrogen (2), and 
Applied Biosystems (ABI, Foster City, CA) reagents, 
products and procedures (a method which is currently 
being optimized by Invitrogen in collaboration with us to 
form an appropriate one-step master mix compatible 
with SuperScript III RT enzyme for reverse 
transcription).  
 
 
Fig. 6: IF-IHC staining for bRSV antigen using Cy3; viewed on a regular 
fluorescence microscope. 
 
Briefly, 100-300 cells (100 laser shots) of a particular cell 
type, as identified during LCM either by IF-IHC or 
morphology, are laser captured onto HS LCM caps using 
a PixCell II laser capture microdissection microscope 
(LCM, Arcturus). We have captured samples using 500 
and 1000 laser shots in the past (in order to increase the 
percentage of intended cell targets and minimize cross-
contaminating cell populations), but it proved to be very 
time consuming and we frequently ran into the problem 
of depleting our intended cell types before capturing 500 
or 1000 spots. We subsequently found that 100-shot 
samples yielded the same results as 1000-shot samples 
(and later found that 20-shot samples worked best). In 
our studies, cells that are CD208+ (Fig. 7), CD208-, bRSV+ 
(Figs. 6 and 8) or bRSV- are considered to be type II 
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pneumocytes, type I pneumocytes, viral antigen-
containing or viral antigen-non-containing cells, 
respectively. 
 
 
Fig. 7: IF-IHC staining for alveolar type II cells (marker; CD208) using Cy3; 
viewed on a regular fluorescence microscope. 
 
Other captured populations include cells adjacent to or 
nearby bRSV antigen-containing cells, while bronchiolar 
epithelial cells were identified and captured solely on the 
basis of morphology. 
 
 
Fig. 8: IF-IHC images obtained during LCM (Cy3 appears as a yellowish 
fluorescence). 
 
New approach to LCM RNA isolation 
 
This new approach to RNA isolation from laser captured 
cells involves the removal of the small round polymer 
tab from each HS LCM cap (onto which the cells have 
been melted by the laser during capture) and processing 
them directly. If one looks closely, one will see that this 
laser-meltable polymer surface is actually applied to each 
cap as a small round ‘sticker’ on the laser capture 
surface. Immediately post capture, these tab/polymer 
stickers are peeled away from each cap with a nuclease-
free instrument (e.g. forceps pre-treated by baking at 
180°C for 6 hours and then sprayed with Ambion’s 
RNAse ZAP then rinsed with nuclease-free water) and 
each is placed into a separate 0.5 ml nuclease-free 
microfuge tube (Product #N8010611, GeneAmp Tube, 
ABI) already containing 10 µl of Lysis Buffer (made up of 
Invitrogen’s Resuspension Buffer, Lysis enhancer and 
RNAseOUT reagents mixed 10 to 1.1 to 1, e.g. 10:1.1:1, 
respectively). The tubes are incubated at 50°C for 10 
minutes in a thermocycler, briefly spun down, and the 
samples are transferred to new 0.5 ml tubes (leaving 
polymer tabs and attached cytoskeletal husks behind in 
the old tubes) and incubated in a thermocycler at 75°C 
for 5 minutes. 1.6 µl 10X DNase I buffer (200 mM 
TRIS:HCl pH 8.4, 40 mM MgCl2, 500 mM KCl, 
Invitrogen) and 5 µl of DNase I (Amplification Grade 
DNase I, Invitrogen) are added and vortexed gently into 
each sample, each is briefly spun down, and this is 
followed by a room temperature incubation of 5 minutes 
(to allow the Amp-Grade DNase I to degrade genomic 
DNA), and samples are again incubated at 75°C either in 
the Arcturus Incubation Block for 5 minutes, or in a 
regular tube rack for 15 minutes to heat-denature DNase 
I enzyme without adding EDTA (we found that adding 
EDTA here severely inhibited all real-time reactions 
using the ABI one-step Master Mix used in this study). 
Next, to minimize non-specific adhesion of RNA to 
positively-charged plastic surfaces (in tubes and plates), 
we add glycogen (Ultrapure Glycogen, 20 µg/µl, 
Invitrogen) to each sample (far in excess, >27,000 times, 
that of the RNA in each sample) so it will most likely 
bind the positively-charged plastic surfaces 
preferentially over the RNA in each sample (3). The 
glycogen stock solution is made by diluting Ultrapure 
Glycogen (Invitrogen) with nuclease-free water 
(Molecular Grade Water, Cat. No. E476-5, MidWest 
Scientific) and 19.4 µl of a 1.4274 µg/µl glycogen solution 
is added to each sample. The concentration of glycogen 
stock solution will vary depending on what final sample 
volumes are to be prepared (e.g. 36 µl final sample 
volumes are prepared here). The goal is to have glycogen 
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end up at the correct desired µg/µl in each of the final 
LCM RNA sample preparations so that its final 
concentration during real-time RT-PCR never rises above 
0.2 µg/µl in each final reaction well – an amount that is 
roughly equivalent to the suggested use of yeast tRNA in 
the same regard – and which is safely below the ‘2 µg/µl 
glycogen limit’ (above which it has been reported to 
inhibit PCR reactions) (4). After glycogen addition, 
samples are gently vortexed and subsequently spun 
down to collect. Sample extracts are then transferred to 
new nuclease-free 0.2 ml microvials (MidWest Scientific) 
and the desired final volume of 36 µl for each sample is 
additionally ascertained during this final sample transfer 
(or samples are used right away in the real-time RT-PCR 
application and not transferred). [Note: when we opt to 
use the RNA samples right away (i.e. without freezing at 
-80°C), we take advantage of the last heating step at 75°C 
(see above) by letting it serve not only as the DNase I 
denaturing step, but also as the template linearization 
step; so samples are placed on ice for at least 1 minute 
after this step and then considered ready for real-time 
RT-PCR at that point]. Before use, isolates that were 
stored at -80°C are heated for 5 minutes at 65°C (in a 
GeneAmp 2400 thermocycler, Perkin Elmer/ABI) 
followed by snap-cooling on ice for at least 1 minute to 
ensure template linearity before use as templates for 
fluorogenic one-step real-time RT-PCR. Samples are 
spun down, and 7.8 µl of each is used as “RNA 
template” in 30-µl fluorogenic one-step real-time RT-
PCR reactions as carried out in 96-well PCR reaction 
plates (ABI) using a GeneAmp 5700 Sequence Detection 
System (ABI) for detection and relative quantification of 
five mRNA targets of interest to us; ovine surfactant 
protein A (SP-A), ovine surfactant protein D (SP-D), 
sheep beta-defensin-1 (SBD-1) bovine/ovine toll-like 
receptor 4 (TLR4) and ovine monocyte chemoattractant 
protein 1-alpha (MCP-1α). For a detailed (EXCEL file) 
look at this particular RNA sample isolation approach, 
refer to Figure 17 (which represents all optimized 
mathematical aspects of the LCM sample RNA 
isolations). Linear amplification is not pursued in our 
approach for a number of reasons: 1) It defeats the 
purpose of a quick method (linear amplification of LCM 
RNA can take up to three days in practice), 2) It is costly, 
(e.g. a commercial amplification kit “RiboAmp HS RNA 
Amplification Kit” costs $695 minimum), and 3) Any 
tampering with RNA samples in effort to amplify or 
reverse transcribe into cDNA invites the risk of skewing 
original RNA profiles, and this in turn can compromise 
real-time qPCR results when such manipulated nucleic 
acid species are used as templates. 
 
Real-time TaqMan assay principle 
 
The principle of the TaqMan reaction is based on the use 
of fluorogenic probes designed to hybridize to the gene 
target sequence of two PCR primers. Each probe contains 
a 5’ fluorescent reporter dye and a 3’ quencher dye. In 
the intact probe, the presence of the 3’ quencher inhibits 
the 5’ reporter emission by quenching its energy 
emission. During the extension phase of PCR cycling, the 
annealed probe is cleaved by the 5ʹ→3ʹ exonuclease 
activity of Taq polymerase. This cleavage produces an 
increase in fluorescence emission of the reporter dye. 
This event occurs each PCR cycle only if the probe has 
annealed to the target sequence, which leads to an 
increase of fluorescence proportional to the initial 
concentration of target sequences in the sample. Such 
real-time fluorescence detection is performed by the ABI 
PRISM 7700 Sequence Detector (Applied Biosystems, 
Inc.). In this instrument, a 96-well thermal cycler is 
connected by fiber optic cables to a CCD camera 
detector. Laser excitation (488 nm) and fluorescence 
detection (between 520 and 660 nm) are performed every 
7 seconds during the entire PCR cycling. The signal 
attributable to the 5ʹ nuclease reaction is expressed as Rn 
values, which represent reporter signal normalized 
against the emission of a passive reference (ROX) minus 
the baseline signal established in the first cycles of PCR 
(conventionally collected from cycles 3-10 on ABI 7300, 
7500 and 7700 machines, or from cycles 6-15 on the 
GeneAmp 5700 machine). This range can also be 
increased up to the cycle immediately prior the 
appearance of the fluorescent signal of more 
concentrated templates, according to the different 
kinetics of amplification. This value increases during 
PCR because the amplicon copy number increases until 
the reaction approaches a plateau. At the same time, the 
algorithm determines the threshold cycle (CT), which 
represents the PCR cycle at which an increase in reporter 
fluorescence above a baseline signal can first be detected. 
The sequence detection software generates a calibration 
curve of CT vs quantity of reference template, and then 
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determines unknowns (quantities) by interpolation. To 
obtain accurate CT values, the baseline needs to be set at 
least two cycles earlier than the CT value for the most 
abundant sample. For real-time quantitative RT-PCR 
data to be meaningful, the threshold should be set when 
the product is in exponential phase. Typically this is set 
at least 10 standard deviations from the baseline. The 
efficiency of the reaction can be calculated from signals 
generated from a target dilution series by the following 
equation: amplification efficiency = 10(-1/slope)-1 (this is not 
to be confused with “exponential amplification” which = 
10(-1/slope)). The efficiency of the PCR, ideally, should be 
90-110% (3.6 ≥ slope ≥ 3.1). A number of variables can 
affect the efficiency of the PCR; length of the amplicon, 
secondary template structure, and primer design, to 
name a few. Although valid data can be obtained that fall 
outside of the efficiency range, the quantitative RT-PCR 
should be further optimized or alternative amplicons 
designed (3). For more extensive background on the 
principles of fluorogenic one-step and two-step real-time 
RT-PCR, visit http://www.ambion.com or 
https://www.appliedbiosystems.com or 
http://www.invitrogen.com. 
 
Real-time reagents, parameters and considerations 
 
In the current communication, master mix and reverse 
transcriptase (RT) enzyme are used as suggested and 
provided in a commercially available kit (Cat. No. 
4309169, TaqMan® One-Step RT-PCR Master Mix 
Reagents Kit, ABI). The Multiscribe (MuLV) RT 
enzyme (10 U/µl) included in the kit arrives already pre-
mixed with RNAse inhibitor (40 U/µl, ABI) as a 40X 
solution. The one-step master mix (which contains 
AmpliTaq Gold hot-start DNA Polymerase, 5.5 mM 
MgCl2, 10 mM of each A, C and G dNTP’s and 20 mM 
dUTP, ROX passive internal reference molecule, a PCR 
product carryover correction component, other ABI-
proprietary buffer components, but no AmpErase UNG 
enzyme) arrives as a separate 2X solution (5 ml total) in 
the kit. Each of our 30 µl one-step real-time RT-PCR 
reactions contain: 15 µl one-step Master Mix, 0.25 U/µl 
Multiscribe RT enzyme, 0.4 U/µl RNAse inhibitor, 
optimal forward and reverse primer and fluorogenic 
probe concentrations (previously established for each 
target using two-step real-time RT-PCR according to 
classic ABI protocol, see below), nuclease-free water, and 
7.8 µl of each LCM-[RNA template] cell extract isolate. 
Before use, all solutions are gently vortexed and spun 
down. Our thermocycling conditions for fluorogenic one-
step RT-PCR are: 35 minutes at 48°C (for reverse 
transcription; normally 30 minutes; ABI), 10 minutes at 
95°C (for AmpliTaq Gold DNA polymerase hot-start 
activation), and 50 cycles of: 15 seconds at 95°C (for 
duplex melting), 1 minute at 58°C (for annealing and 
extension; normally 60°C; ABI). [Note: we altered the 
ABI-suggested thermocycling conditions for their one-
step master mix in favor of what we found to be more 
optimal for our particular targets]. For recent real-time 
results using this IF-IHC-LCM-RT-PCR method, see 
Figures 9-10. 
 
 
Fig. 9: Bovine respiratory syncytial virus (bRSV) RNA signal: The bRSV 
amplification plots here correspond to each of the samples in Figure 10 
(below) analyzed for ovRS15. These signals were attained from the 
equivalent of RNA from about 21 cells in each case. 
 
In addition, Figure 11 shows that we have recently 
detected one-step real-time RT-PCR signal in samples 
containing RNA from the equivalent of a single cell 
(using the common assumption that one mammalian cell 
contains 10-30 pg of total RNA, but upon isolation, yields 
~10 pg of RNA). 
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Fig. 10: Ovine Ribosomal S15 mRNA signal: The ovRS15 amplification 
plots below correspond to each of the samples in Figure 9 analyzed for 
bRSV (above). These signals were attained from the equivalent of RNA 
from about 21 cells in each case. 
 
We abandoned the use of 18S Ribosomal RNA as 
housekeeper (see also Appendix A, item 6), since the 
primers and probe provided as part of an ABI RNA 
control reagents kit were of a faulty design (22). Instead, 
we used ovine ribosomal protein S15 (ovRPS15) as the 
housekeeping (endogenous reference) gene, the sequence 
of which we received from Dr. Sean Limesand 
(Department of Pediatrics University of Colorado Health 
Sciences Center, Perinatal Research Center, PO Box 6508, 
F441, Aurora, Colorado 80045), which he had 
successfully cloned into a pCRII plasmid and used as a 
housekeeping gene with conventional PCR work in 
sheep pancreas: 
 
ovRPS15 in pCRII as read from the T7 promoter: 5’-
TTCCGCAAGTTCACCTACCGCGGCGTAGACCTCGA
CCAGCTGCTGGACATGTCCTATGAGCAACTGATGC
AGCTATACAGCGCGCGCCAGCGACGGCGGCTGAA
CCGCGGCCTGCGGAGGAAGCAGCACTCGTTGCTG
AAGCGGCTGCGCAAGGCCAAGAAAGATGCGCCGC
CCATGGAGAAGCCCGAGGTGGTGAAGACGCACCT
GCGCGACATGATCATTCTGCCCGAGATGGTGGGCA
GCATGGCCGGCGTCTACAACGGCAAGACCTTCAA
CCAGGTGGAAATCAAGCCTGAGATGATTGGCCACT
ACCTAGGCGAGTTCTCCATCACCTACAAGCCCGTA
AAGCATGGCCGGCCCG-3’. 
 
Fig. 11: Sensitivity of the assay: RNA from the equivalent of a single cell 
infected with bRSV was analyzed for the presence of bRSV and ovine 
ribosomal S15 mRNA (housekeeping gene). From this recent result, we 
now feel confident that the collection of 10 to 20 cells by LCM for the 
purposes of IF-IHC-LCM-RT-PCR is the optimal number—not only to save 
time, but also to avoid collecting cellular debris on unintended portions of 
the cell-collection surfaces of the HS LCM caps resulting from picking up 
and setting down the caps on tissue samples multiple times in effort to 
collect 100, 500 or 1000 cells or more. We have shown this ‘debris’ to 
inhibit real-time RT-PCR reactions. The sensitivity of this assay will now 
allow us to avoid having to pick up the LCM caps multiple times. 
 
We designed real-time primers and probe to this 
ovRPS15 sequence using computer software from ABI 
(Prism Primer Express v. 2.0). Our sequences for the 
forward and reverse primers and fluorogenic probe for 
ovRPS15 are: 5’- CGAGATGGTGGGCAGCAT-3’, 5’-
GCTTGATTTCCACCTGGTTGA-3’, and 5’-VIC-
CCGGCGTCTACAACGGCAAGACC-TAMRA-3’ (where 
VIC is a proprietary fluorescent reporter dye known 
only by its 3-letter acronym; a trademark of Applera 
Corporation). We also designed sequence-specific 
oligonucleotide primers and fluorescent probes for our 
other real-time targets of interest (SBD-1, SP-A, SP-D, 
ovine MCP-1α and TLR4) using Primer Express v.2.0 in 
conjunction with the search tool BLAST (Basic Local 
Alignment Search Tool, National Center for 
Biotechnology Information). Resultant probe sequences 
are checked for specificity by comparing them for 
similarity to all other available sequences in the database. 
Only unique sequences and/or sequences that spanned 
genomic introns are used for our SP-A, SP-D, SBD-1, 
MCP-1α and TLR4 primer and probe designs. We 
identified ovine TLR4 real-time primers and probe by 
trial and error using the bovine sequence for TLR4 
(accession number NM 174198) as a general ruminant 
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TLR4 template. The second real-time primer-probe set 
we designed for ovine TLR4 (and tested on ovine lung 
total cDNA) worked beautifully. The forward and 
reverse primers and fluorogenic probe for “ovine” TLR4 
is as follows:  
 
5’-GAGAAGACTCAGAAAAGCCTTGCT-3’, 5’-
GCGGGTTGGTTTCTGCAT-3’ and 5’-6FAM-
TAAACCCCAGAGTCCAGAAGGAACAGCA-3’, respectively. 
The primer and probe sequences for our other targets 
are: for SP-A, 5’-TGACCCTTATGCTCCTCTGGAT-3’, 5’-
GGGCTTCCAAGACAAACTTCCT-3’, and 5’-6FAM-
TGGCTTCTGGCCTCGAGTGCG-TAMRA-3’; for SP-D, 
5’-ACGTTCTGCAGCTGAGAAT-3’, 5’-
TCGGTCATGCTCAGGAAAGC-3’, and 5’-6FAM-
TTGACTCAGCTGGCCACAGCCCAGAACA-TAMRA-
3’; for SBD-1, 5’-CCATAGGAATAAAGGCGTCTGTGT-
3’, 5’-CGCGACAGGTGCCAATCT-3’, and 5’-6FAM-
CCGAGCAGGTGCCCTAGACACATGA-TAMRA-3’ and 
for ovine MCP-1α (the sequence used for ovine MCP-1α 
primer and probe design: 5’-
GAGAGGGGCCAATCCAGAGGCCAACAGCTCCCAC
GCTGAAGCTTGAATCCTCT CGCTGCAACATGA 
AGTTCTCCGCTGCTCTCCTCTGCCTGCTACTCACAG
TAGCTGCCTTCAGCACCGAGGTGCTCGCTCAGCCA
GATGCAATTAACTCCCAAATTGCCTGCTGCTATAA
ATTCAATAAGAAGATCCCCATACAGAGGCTGACA
AACTACAGAAGAGTCACCACCAGCAAGTGTCCCA
AAGAAGCTGTGATTTTCAAGACCATCCTGGGCAAA
GAGTTTTGTGCAGACCCCAACCTGAAATGGGTCCA
GGACGCCATAAACCATCTCAACAAGAAAAACCAA
ACTCCGAAGCCTTGA-3’ was provided in a recent 
publication (5)):  
 
5’-GCTGTGATTTTCAAGACCATCCT-3’, 5’-
GGCGTCCTGGACCCATTT-3’, and 5’-6FAM-
AAAGAGTTTTGTGCAGACCCCAACC-TAMRA-3’; (where 
6FAM is 6-carboxyfluorescein, the fluorescent reporter 
dye, and TAMRA is 6-carboxytetra-methylrhodamine, 
the fluorescent quencher dye). We determined our 
optimal real-time concentrations for target and 
endogenous reference forward and reverse primers 
using the standard grid testing method as suggested by 
ABI (see “Additional Details Regarding Optimizing Real-
Time Primers and Fluorogenic Probes Before their use 
with Experimental Samples: Optimization and validation 
tests performed on cDNA” section below for more 
details). Our optimal concentrations were: 300 and 300 
nM for ovine SP-A, 300 and 300 nM for ovine SP-D, 300 
and 900 nM for SBD-1 forward and reverse primers (6), 
900 and 400 nM for ovine MCP-1α and 1000 and 1000 nM 
both for ovine TLR4 and ovRPS15 forward and reverse 
primers, respectively. Similarly, optimal concentrations 
of fluorogenic probes are found to be 50 nM for SP-A, 
100 nM for SP-D, 150 nM for SBD-1, 100 nM for TLR4, 
100 nM for ovine MCP-1α and 150 nM for ovRPS15. Each 
plate contained both target and endogenous references 
for all samples present on that plate, and a negative no-
template control (“NTC”; nuclease-free water) for each 
target and endogenous reference. No reverse 
transcriptase controls or “NRC” (one-step reactions 
containing everything except reverse transcriptase 
enzyme to test for genomic DNA contamination) are run 
on each RNA sample in separate plates prior the actual 
sample plates. Duplicate replicates are run for each of 
these time-intensive LCM samples. 
 
Preparation of cDNAs for preliminary target 
calibration (standard) curve runs 
 
Using the GeneAmp 5700 software and EXCEL, relative 
quantities of each target are calculated from all real-time 
CT values crossing a threshold of 0.1 using 5-point serial 
progressive 1:3 standard curves generated months 
beforehand specifically for each target (SP-A, SP-D, SBD-
1, TLR4, MCP-1α and ovRPS15) using cDNAs made from 
a mixture of 7 different sheep lung total cDNAs (bearing 
all real-time targets of interest) generated by reverse 
transcription with SuperScript III RT enzyme as follows: 
Total RNA is isolated from 0.3 grams of sheep lung 
tissue using our own optimized procedure (6). All total 
RNA isolates are assessed for quantity and purity by 
examining 1:50 dilutions of each by spectrophotometry 
at 260nm and 280nm, and DNase treatment is performed 
using the TURBO DNA-free kit from Ambion. DNase 
treatment mixtures are vortexed gently, then incubated 
in a 2400 thermocycler (Perkin Elmer/ABI) for 30 minutes 
at 37°C. 1 µl DNase Inactivation Reagent per 10 µl 
solution is added to each tube. The tubes are incubated 
for 2 minutes at room temperature with intermittent 
vortexing every 10 to 15 seconds, then centrifuged at 
10,000 x g for 1.5 minutes to pellet the Inactivation 
Reagent. The upper transparent layer containing the 
RNA is transferred to a new tube (care is taken to avoid 
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~15-25% of the solution on the bottom of each tube – 
which is the pelleted Ambion DNase Inactivation 
Reagent polymer complex that can inhibit PCR 
reactions). Next, complementary deoxyribonucleic acid 
(cDNA) synthesis is performed. Reverse transcription 
master mix containing 3.38% nuclease-free water, 31.17 
mM TRIS, 64.94 mM KCl, 5.71 mM MgCl2, 2.08 mM 
dNTP mix, 2.6 µM random hexamers and 0.0222 µg/µl 
TURBO DNase-treated RNA is heated for 5 minutes at 
65°C then snap-cooled on ice for at least 1 minute. [Note: 
We made our own 10X reverse transcription buffer (300 
mM TRIS:HCl, 625 mM KCl, pH 8.3) and used it in the 
master mix above. Additionally, our TURBO DNase-
treated RNAs are all pre-diluted such that the addition of 
36 µl to each final 100 µl reverse transcription reaction 
resulted in each reaction containing 2.1389 µg total RNA 
template; and two to four such 100 µl reactions are 
created from the same original reverse transcription 
master mix for all samples]. Samples are spun down, and 
RNAse inhibitor (20 U/µl, ABI) and SuperScript III RT 
enzyme (200 U/µl, Invitrogen) are finally added to each 
cooled sample reverse transcription mixture (now 200 to 
400 µl each). The final concentrations attained of each 
reverse transcription component are: 3.25% nuclease-free 
water, 30 mM TRIS, 62.5 mM KCl, 5.5 mM MgCl2, 2 mM 
dNTPs (0.5 mM each of dATP, dCTP, dTTP and dGTP), 
2.5 µM random hexamers, 3.5 U/µl SuperScript III RT 
enzyme, 0.4 U/µl RNAse inhibitor and 0.021389 µg/µl 
TURBO DNase-treated RNA. These reagents are 
vortexed gently, split into 100 µl amounts into nuclease-
free 0.2 ml tubes (MidWest Scientific), and the tubes are 
placed into the GeneAmp 2400 thermocycler (which only 
accepts samples of 100 µl or less). Reverse transcription 
thermocycler conditions are: 5 minutes at 25°C, 45 
minutes at 53°C, 15 minutes at 70°C, followed by a safety 
hold at 4°C. 
 
Standard curves generated for each target had the 
following equations when plotted as log input cDNA vs 
Ct: for SP-A, y = -3.5491x + 31.0207; R2 = 0.9725, for SP-D, 
y = -2.8747x + 31.9853; R2 = 0.9525, for SBD-1, y = -4.5093x 
+ 35.2325; R2 = 0.7713, for TLR4, y = -4.2945x + 33.7240; R2 
= 0.8068, for MCP-1α, y = -3.7496x + 32.5020: R2 = 0.9138, 
and for ovRPS15, y = -3.8041x + 27.8233; R2 = 0.9881. It is 
important to note here, however, that running standards 
on all plates (from which to generate standard curves for 
each target on each plate) remains the most accurate 
approach toward attaining reliable real-time quantitation 
data since standard and sample reactions for the same 
target on the same plate experience the same degree of 
amplification reaction efficiency (or, indeed, 
inefficiency). 
 
Normalization 
 
For the LCM RNA samples (on which we used the 
optimal primer and probe conditions as established with 
cDNA in preliminary studies), each target signal mRNA 
level is normalized to its respective ovRPS15 signal by 
dividing the target input amount quantity value of RNA 
by the ovRPS15 input amount quantity value of RNA for 
each. This is followed by calculating the average and 
standard error of the mean for all replicates per each 
particular sample group. For cell culture studies, we 
have used 18S ribosomal RNA (but samples are diluted 
1:1000 before use because of its hyper-abundance in 
comparison to mRNA targets) as a housekeeper (in 
addition to ovRPS15), in which case we use the 
geometric mean of the ribosomal protein S15 and 18S 
ribosomal RNA values to normalize our target signals. 
Other researchers have suggested using up to 10 
different housekeeping genes for each experiment – 
which is too costly and impractical for most. We now 
avoid the use of β-actin, β-tubulin and GA3PDH as 
housekeeping genes since their stability (and therefore 
usefulness) has come under extensive fire recently, and 
over the past few years. 
 
Additional details regarding optimizing real-time 
primers and fluorogenic probes before their use with 
experimental samples 
 
Optimization and validation tests performed on 
cDNA 
 
Weeks and months prior to final sample RNA analyses 
by one-step fluorogenic real-time RT-PCR, each primer-
probe set (with the exception of the ABI pre-optimized 
18S ribosomal RNA primer-probe set) first had to be 
evaluated with cDNA for optimal primer and probe 
concentrations to ensure that maximal real-time 
fluorogenic PCR kinetics is obtained in each case (see 
Appendix A-E). These optimization and validation 
experiments are performed on cDNA exactly as 
suggested by ABI in order to find the correct 
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concentrations of primers and probes to use for each 
target, as well as the optimal useful dilution of cDNA 
template (found to be 1:5 for our purposes) to use that 
would allow each PCR to proceed with optimal 
efficiency. To accomplish this, two separate optimization 
plates are set up for each target; the second of which can 
only be set up after results from the first plate are 
obtained in each case. In other words, each target 
required one plate to optimize primer concentrations and 
another plate to optimize probe concentration. The first 
plate in each case is designed to enable the testing of 
various combinations and concentrations of the forward 
and reverse primers ranging from 50 nM to 900 nM while 
the probe amount remained fixed. In each well, the 50 µl 
PCR mixtures contained a constant concentration of 
target probe (200 nM), 5 µl of 1:5 diluted target-inclusive 
“Stock I cDNA” [* footnote at end of section], 25 µl of a 
commercial master mix (Cat No. 4304437, TaqMan 
Universal PCR Master Mix 2X, ABI, and nuclease-free 
water (which is used to adjust each final volume to 50 µl 
after the desired primer and probe amounts are added). 
For all optimization trials, each sample is analyzed in 
quadruplicate, so each final sample preparation is 200 µl 
in each case. We create and use master mixes whenever it 
is beneficial, logical and appropriate to do so throughout 
each real-time procedure. Each primer optimization plate 
is run in a GeneAmp 5700 real-time PCR machine 
(GeneAmp 5700 Sequence Detection System, ABI) using 
the following thermocycler conditions (which is used for 
all two-step fluorogenic real-time qPCR runs in this 
study; it is a specific thermocylcer program created and 
optimized by ABI to be used specifically with cat. no. 
4304437, TaqMan Universal PCR Master Mix 2X, and two 
or three other related ABI 2X Master Mix reagents): Hold 
for 2 minutes at 50°C (to activate the AmpErase UNG 
enzyme which destroys any dUTP-containing PCR 
carryover products left over in the PCR room from 
previous runs that may have drifted into your tubes 
during set-up), Hold for 10 minutes at 95°C (to “hot-
start” activate the AmpliTaq Gold® DNA polymerase) 
and then 50 cycles of 15 seconds at 95°C followed by 1 
minute at 60°C (to accomplish the annealing and 
extension phases of the PCR). Each 50-cycle run lasted 2 
hours and 14 minutes, after which the GeneAmp 5700 
sequence detection system software and Microsoft 
EXCEL are used in conjunction with one another to 
analyze the resultant fluorogenic PCR amplification data. 
For the first optimization plate for each target, primer 
amounts that, upon analysis, provided the highest Rn 
value (see below) with the lowest primer 
concentration(s), are identified as the optimal 
concentrations for each primer pair for each of the 
respective targets of interest. To test each probe for 
optimal efficiency, a second plate is designed for each 
target to enable the testing of various concentrations of 
each probe ranging from 25 nM to 225 nM in the 
presence of optimal primer concentrations (as 
established by plate 1 in each case). For each probe, in 
each well, each 50 µl PCR reaction contained the 
identified optimal concentrations of each primer for each 
target (which we found to be 300 nM and 300 nM for 
ovine SP-A, 300 nM and 300 nM for ovine SP-D, 300 nM 
and 900 nM for SBD-1, 900nM and 400 nM for ovine 
MCP-1α, 1000 nM and 1000 nM for ovine/bovine TLR4, 
and 1000 nM and 1000 nM for ovine RPS15 forward and 
reverse primer concentrations, respectively), 5 µl of 1:5-
diluted Stock I cDNA, 25 µl of the ABI commercial 
master mix (mentioned above) and nuclease-free water. 
Each separate primer-probe study in each of these 
optimization plates for each target is run in 
quadruplicate replicates in order to enhance the 
statistical significance of each sample observation (in all 
cases, quadruplicate sample well signals agreed to within 
>0.01%, lending high credence to the technique’s 
stability, data not shown). This second (probe-
optimization) plate is run in the GeneAmp 5700 sequence 
detection system using the same thermocycler program 
as used for the first (primer-optimization) test plate. For 
the second plates for each target, upon analysis of the 
resultant data, the combination of reactants which 
yielded the lowest CT (the threshold cycle or the CT value 
is the cycle at which a significant increase in ΔRn is first 
detected; where ΔRn is calculated from Rn+ and Rn-, 
where Rn+ is the Rn value of a reaction containing all 
components, Rn- is the Rn value of an unreacted sample 
(the baseline value or the value detected in the no-
template control, NTC). ΔRn is thus the difference 
between Rn+ and Rn- and it is an indicator of the 
magnitude of the signal generated by the PCR; see ABI 
literature for further information) with the lowest probe 
concentration is chosen as the optimal fluorogenic probe 
concentration in each case (which we found to be 50 nM, 
100 nM, 150 nM, 100 nM, 100 nM and 150 nM for ovine 
SP-A, ovine SP-D, SBD-1, ovine MCP-1α, ovine/bovine 
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TLR4 and ovine RPS15 probes, respectively). Next, as a 
validation test that the target and endogenous reference 
cDNA amplification reactions are all proceeding at equal 
efficiency across a spectrum of Stock I cDNA 
concentrations, a third plate (the validation test plate) is 
designed to enable the testing of various concentrations 
of cDNA ranging from full-strength Stock I cDNA to a 
1:15,625 (i.e. attained by the seventh dilution in a series 
of progressive 1:5 dilutions) dilution of Stock I cDNA. In 
each well, constant (optimal) concentrations of forward 
and reverse primers and constant (optimal) 
concentrations of probe are used along with 25 µl of ABI 
(Cat No. 4304437) master mix, 5 µl of sequentially-
diluted Stock I cDNA and nuclease-free water. Also 
included on this plate, are wells identical to the ones just 
described, but instead of ovine target primers and probe, 
they contained the endogenous reference (human 18S 
ribosomal RNA) forward and reverse primers and probe 
at their (ABI-established) optimal real-time 
concentrations (50 nM primers and 200 nM probe). This 
plate included all samples in triplicate and was run in the 
GeneAmp 5700 sequence detection system using the 
same universal thermocycler protocol as used for the 
preceding tests, and the data is subsequently analyzed. 
 
Real-time quantitation 
 
An additional result of running validation plates is that 
they provide the researcher the characteristic standard 
curves (also referred to as ‘calibration’ or ‘dilution’ 
curves) for each target. Using standard curve y-intercepts 
and slopes in the following apparently unpublished 
equation: [real-time relative target quantity (or Qty) = 
10((Ct-b/m)] (as indirectly alluded to in ABI’s Technical 
Bulletin #2) (7), much in the same way the Pfaffl equation 
is utilized or approached (8), we calculate all normalized 
relative mRNA expressions for each target of interest and 
compare fold differences in normalized target expression 
between different treatment groups. Significant 
differences between groups are determined using the 
appropriate two-tailed homoscedastic t-test, or one-tailed 
t-test (as suggested by ABI) when appropriate (also see 
Appendix G). But again, it is important to note here, that 
running standards on all plates (from which to generate 
standard curves for each target on each plate) remains 
the most accurate approach toward attaining reliable 
real-time quantitation data since standard and sample 
reactions for the same target on the same plate will both 
invariably experience the same degree of amplification 
reaction efficiency (or, indeed, inefficiency). Standard 
curves are prepared for each gene under study for RNA 
quantitation (absolute or relative quantitation), or for 
verification of the efficiencies of the reactions for 
comparative quantitation (using the ΔΔCT method which 
is only valid when target and reference standard curve 
slopes are within ±0.1 units of one other; a seldom useful 
approach in practice). Standard curves are all 
constructed to extend above and below the expected 
abundance of each target. Sometimes (especially during 
target primer and probe validation runs), additional 
input quantities are included such as the minimum and 
maximum RNA amounts above and below the limit of 
detection to help differentiate between specific and non-
specific products.  
 
*“Target-inclusive Stock I cDNA” refers to a pre-selected sheep cDNA 
from which it is shown by preliminary, non-optimized real-time test 
plates to express positively for all targets of interest to the study. The 
1:5 dilution refers to the dilution of “full-strength” Stock I cDNA (or 
any other sample cDNA whose original concentration is that which is 
obtained directly from each RT reaction; which is theoretically 0.02 
µg/µl cDNA, assuming 100% efficiency of each reverse transcription as 
described here). 
 
CONCLUSIONS 
 
We report here, a very fast, fail-safe way to isolate one-
step real-time quantitative RT-PCR-quality RNA from 
LCM samples using the combined technologies of 
Invitrogen, Arcturus and Applied Biosystems. Our work 
has revealed that RNA extracted in this way is stable for 
weeks when stored at -80°C, but, RNA isolated from 
slides older than 8 days (slides stored at -80°C) start to 
show weaker real-time signals from all targets 
investigated. Peeling the polymer tab off of the Arcturus 
HS LCM caps immediately post capture and extracting 
the RNA directly off the polymer tabs has proven to us to 
be the easiest and most efficient approach to isolate RNA 
from LCM samples. Minimizing the number of times one 
picks up the HS LCM caps during LCM is also crucial 
since cellular debris collected on the capture surface 
builds up the more one picks up and sets down the caps 
to find new collection areas. Subsequently, this debris 
also gets extracted during RNA isolation as well, and we 
have observed that RNA samples containing such debris 
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exhibit significantly poorer signals during one-step real-
time RT-PCR (unpublished observations). Since we now 
have improved the sensitivity of the assay by employing 
this new approach to RNA isolation, the need to pick up 
the HS LCM caps multiple times in order to collect 
enough cells for ample real-time signal has been 
effectively eliminated. It is additionally important to note 
here that the maximum volume of [RNA isolate] sample 
per each 30 µl reaction is 7.8 µl. The RNA sample can not 
exceed 26% of the total reaction volume or the master 
mix components themselves begin to incur dilution (by 
sample) beyond their suggested optimal real-time 
concentrations. This is why we use 7.8 µl-size samples 
per each 30 µl reaction. In addition, eliminating EDTA 
addition after DNAse I treatment (1 µl of 25 mM is 
normally added to each sample before denaturing DNase 
I at 75°C as suggested in the SuperScript™ III CellsDirect 
cDNA Synthesis System protocol by Invitrogen) is key to 
maximizing the signal magnitude of our target 
amplifications. We found the ABI one-step master mix 
(TaqMan One-Step RT-PCR Master Mix Reagents Kit 
Cat. No. 4309169, ABI) to be susceptible to additional 
EDTA, whereas other master mixes (Invitrogen) may 
withstand higher amounts. Conceivably, additional Mg+2 
could be added to the ABI master mix to help restore its 
activity (if indeed EDTA addition during DNase I 
denaturation is needed in some cases), but we have not 
tried that approach presently. Our –RT (NRC) controls 
consistently show very little DNA contamination, see 
Figures 12-14 (Ginger Lucero, M.F.S., Invitrogen).  
 
 
Fig. 12: Results from Invitrogen show that our typical -RT controls are 
valid. 
 
Further, addition of glycogen to our isolates appears to 
have no effect (positive or negative) on our ability to 
detect real-time signals (Fig. 13), so researchers may 
consider eliminating glycogen from this procedure 
without consequence. 
 
 
Fig. 13: Results from Invitrogen show results from 50 cell samples. 
 
Finally, using the approach laid out in this 
communication, we can now consistently detect one-step 
fluorogenic real-time RT-PCR targets in single-cell 
amounts of RNA (Fig. 11). For an excellent 
comprehensive review on all possible aspects of 
quantitative real-time PCR (qPCR), see works by Stephen 
A. Bustin, (9), Mocellin et al., (10), and for RNA 
amplification, see Wang et al., (11). Our lab has published 
several papers which describe in depth the nature and 
quality of our qPCR approach. To check the quality of 
our real-time qPCR protocols in greater detail, please 
review our previous publications in their entirety (12-21). 
 
 
Fig. 14: Real-time results from Invitrogen using 3, 10 and 100 laser 
captured cells. 
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SUPPLEMENTAL INFORMATION 
 
EXCEL files for processing any part of these experiments 
are available from the corresponding author, Jack M. 
Gallup (eag@iastate.edu), upon request. 
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APPENDICES AND ADDITIONAL FIGURES 
 
 
Fig 15: Typical section used for LCM, a 6 µm section of sheep lung is shown here. 
 
 
 
Fig. 16: To process and use tissues:  we first fill a plastic cryo-mold half way with OCT, then we freeze the OCT partially (just the edges), place the 
tissue in center, cover tissue with OCT, freeze until opaque (this is most quickly performed in a dry-ice/ethanol bath, but we have successfully 
performed this on dry-ice alone as well). We cut sections on a cryostat (after cleaning cryostat with ethanol), and then we store the resulting slides 
@ -80°C (and never let them thaw). Upon use, we take slides from -80°C fridge and place them either directly into 95% ethanol (with no PBS or 
water exposure at all), or, if pursuing IF-IHC before LCM, slides are placed directly into cold nuclease-free PBS + 0.1% Tween 20. 
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Fig. 17: EXCEL file layout detailing RNA extraction/isolation procedure where polymer tabs with laser 
captured cells are first peeled off the HS LCM caps and then processed. 
 
 
Fig. 18: EXCEL file layout detailing RNA extraction/isolation procedure where polymer tabs with laser 
captured cells are first peeled off the HS LCM caps and then processed. 
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Fig. 19: An Arcturus HS LCM Cap. 
 
 
Fig. 20: The removable polymer tab (onto which cells are laser-
captured) being lifted by forceps. 
 
 
Fig. 21: The removed polymer tab; if desired, one can additionally 
trim the tabs closer to the central region where the captured cells are 
using a nuclease-free pair of scissors. 
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Fig. 22: The ABI 0.5 mL GeneAmp tube containing 10 uL Lysis Buffer.  
 
Appendix A 
 
All primers and probes were optimized and validated strictly according to ABI procedural guidelines using all-target-
inclusive cDNA prepared from Turbo DNase-treated total RNA isolated (using Trizol) from whole sheep lung 
homogenates. Our optimization approach is a very common/well-known procedure whereby one studies 
combinations of primer concentrations in the range of 50 nM-900 nM while keeping the probe at a constant 200 nM, 
then the probe is challenged from 25 nM to 225 nM at the optimal primer concentrations established above. All 
samples are performed in quadruplicate during these procedures. After optimization, the validation runs are 
performed on seven serial 1:5 dilutions of the same cDNA (starting with full-strength cDNA being assigned the 
relative strength of “1”) using the optimal primer and probe concentrations established during optimization. The 
highest Rn (normalized reporter fluorescence) value with the lowest primer concentrations is the indicator by which 
one selects the appropriate optimal primer concentrations in each case. The higher the Rn, the higher the magnitude of 
real-time fluorescent signal. Once the Rn value no longer increases with increasing primer concentrations, one has 
attained the useful optimal primer concentrations. Ct values are inspected during probe optimizations, and the lowest 
Ct (threshold cycle) value with the lowest probe concentration is the criteria by which one chooses the optimal probe 
concentration. Once the Ct value no longer decreases with increasing probe concentration, one has attained the useful 
optimal probe concentration. Little known is the fact that all real-time target signals can be found with greater than 
50% amplification efficiency simply using 1000 nM primers and 150 nM probe (unpublished observations from our 
lab). 
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Appendix B 
 
Fig. 23: Typical EXCEL file set-up for primer-probe optimizations and validations. 
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Appendix C 
 
Fig. 24: Real-Time probe optimization test following primer optimization. 
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Appendix D 
 
 
Fig. 25: Typical Validation run result for testing optimal primer and probe optimizations (note – these 
validation curves additionally serve as target standard curves as well). 
 
Appendix E 
 
Our “validation” tests are never performed on RNA – only on cDNA, and for obvious reasons: it is not valid to 
optimize real-time PCR using RNA since the RT step in a One-Step procedure is prone to variable degrees of efficiency 
(or, one should assume it to be; recent seminars on real-time qPCR have stressed this), and the reverse primer is used 
up to an unknown extent during 1st-strand synthesis. For validation, Turbo-DNase-treated total RNAs are first 
converted to total cDNAs (using SuperScript III RT enzyme, Invitrogen) in a tightly controlled RT reaction using 2 ug 
RNA per each 100 uL RT reaction. To assess concentration of each RNA isolate before DNase treatment, 
spectrophotometer readings of 1:50 dilutions of each are taken at 260 nm, 280 nm and 230 nm to check for: RNA 
concentration (260 nm), RNA purity (260/280; our RNA ratios are typically >1.92), and GIT, EDTA and/or TRIS 
contamination (230 nm; 260/230 ratios are acceptable if >2.0 here; ours are consistently >2.0). 
 
Appendix F 
 
We no longer use the ABI primer-probe set for 18S ribosomal RNA for assessing RIBO 18S as a housekeeping gene 
because of its faulty design (22). Our newly-designed set for RIBO 18S will help us establish a consistent RIBO 18S 
signal in our LCM samples we believe. In addition, we also use ovine RPS15 as a second housekeeper. 
 
Appendix G 
 
We haven’t had the need to generate dose-dependent line graphs for our qPCR studies. Our mathematical approach 
already takes into account the Pfaffl approach, and is aware of the theoretical ramifications of equations offered by 
Swillens et al. and Foster et al., (23, 24). The typical EXCEL spreadsheet we’ve designed for calculating absolute or 
relative real-time target quantities greets the strongest principal approach in qPCR, which is to always run calibration 
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curves for all targets multiple times to prove the consistency of the efficiency of amplification for each target, and, 
always include a standard curve for each target on every plate (very rarely does one see two different target 
amplification reactions exhibit identical efficiencies!). Finally, no template controls (“NTC”) and no reverse 
transcriptase controls (“NRC”) are run for all samples as well. No amplification controls (ʺNACʺ), which contain no 
Taq polymerase enzyme, are run on separate plates by themselves for each RNA isolate. 
 
 
Fig. 26: Our typical relative-quantitative real-time qPCR EXCEL worksheet based on the strongest qPCR 
mathematical principles. These values are then used to perform one or two-tailed t-tests on – in 
accordance with the statistical guidelines as currently suggested by ABI (3). 
 
 
 
 
 
